Literature DB >> 8002738

[Left ventricular involvement in mucoviscidosis after 2 years of age].

P Ambrosi1, J P Chazalettes, L Viard, M Raynaud, G Faugere, M Noirclerc, P J Bernard.   

Abstract

BACKGROUND: The cardiac involvement in cystic fibrosis includes the rare cardiomyopathy seen in infants and changes in left ventricular performance in older children. POPULATION AND METHODS: 67 patients, 6 to 34 months-old (mean: 16.7), 37 male and 30 female, with cystic fibrosis, were studied. Their Shwachman score was < 70. None showed any clinical manifestations of left ventricular insufficiency, but 6 patients had right ventricular insufficiency. Echocardiography was performed on 58 patients; it showed dilation of the right ventricle in 32 of them. Left ventricular perfusion was studied with thallium 201 tomoscintigraphy and left ventricular ejection fraction with 99mTc ventriculography.
RESULTS: The left ventricular ejection fraction was < 45% in 17 patients and scintigraphy showed hypofixation in 6 of them. In contrast, only 4 of the 50 patients with left ventricular ejection fraction > 45% had thallium hypofixation.
CONCLUSIONS: Resting perfusion abnormalities are more frequent in patients with a low left ventricular ejection fraction. These perfusion abnormalities suggest that myocardial fibrosis complicates the advanced stages of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8002738

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  2 in total

1.  Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate.

Authors:  Zachary M Sellers; Vania De Arcangelis; Yang Xiang; Philip M Best
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

2.  Left ventricular and aortic dysfunction in cystic fibrosis mice.

Authors:  Zachary M Sellers; Attila Kovacs; Carla J Weinheimer; Philip M Best
Journal:  J Cyst Fibros       Date:  2012-12-24       Impact factor: 5.482

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.